1st Edition

Cancer, Radiation Therapy, and the Market

By Barbara Bridgman Perkins Copyright 2017
250 Pages
by Routledge

250 Pages 15 B/W Illustrations
by Routledge

250 Pages 15 B/W Illustrations
by Routledge

Appraising cancer as a major medical market in the 2010s, Wall Street investors placed their bets on single-technology treatment facilities costing $100-$300 million each. Critics inside medicine called the widely-publicized proton-center boom "crazy medicine and unsustainable public policy." There was no valid evidence, they claimed, that proton beams were more effective than less costly... Read more

1. Medical Care as Trade

PART I

Radiation Enterprise, 1895 to World War II

2. The Medical Radium Industry

3. The General Electric Company Dominates X-ray

4. Competing Research Universities

PART II

Competitive Megavoltage, World War II to the 1970s

5. Megavoltage Competition in Academia and Industry

6. Medicine’s Nuclear Arms Race

7. An Economic Success Story at Stanford

8. Radiation Therapy Politics

PART III

Financializing Medicine, 1970s to the 2010s

9. Speculating on Proton Therapy

10. Rationalizing Radiation Therapy, Reforming Health Care

11. Choosing Health Over Wealth

 

Selected Bibliography

Index

Biography

Barbara Bridgman Perkins is the author of The Medical Delivery Business: Health Reform, Childbirth, and the Economic Order and articles in medical history and public health policy.

 "Do commercials for Gamma Knife, proton therapy and other types of radiosurgery for cancer fill you will both hope and trepidation? If so, you should read Cancer, Radiation Therapy, and the Market. Barbara Bridgman Perkins has written a wise and fastidiously-researched history of radiation oncology that explores the intersection of big business, the zeal to cure cancer and the unending allure of the x-ray."

Barron H. Lerner, Author of The Breast Cancer Wars: Hope, Fear and the Pursuit of a Cure in Twentieth-Century America and